The rates of coronary heart disease are lower in Asia than in developed countries. Singapore has undergone rapid urbanization over the past several decades. In the several decades between the 1960s and 1980s, a rapid increase in the rates of ischemic heart disease was observed, to the extent that Singapore exhibits one of the highest rates of mortality from cardiovascular disease in the Asia-Pacific region, higher even than the rates in North America. Rates of cardiovascular disease have now stabilized, and are declining. This is, a pattern that has been observed in many developed countries. Increased life expectancy has resulted in an epidemiologic transition that has seen chronic non-communicable diseases replace malnutrition and infections as the major causes of mortality. At the same time, there have been changes in nutrient intake and physical activity as well as rapid increases in the levels of several cardiovascular risk factors including obesity, hypertension, hyperlipidemia, diabetes mellitus and systemic inflammation. Furthermore, when present, there is a lack of awareness and sub-optimal treatment of these risk factors. In addition to the changes in environmental exposures related to socio-economic development, it does appear that specific populations are particularly prone to the development of cardiovascular disease and its risk factors. In particular, Asian Indians experience a high rate of coronary heart disease and diabetes mellitus. Emerging data suggests that Chinese may be particularly prone to the adverse effects of obesity in relation to insulin resistance and inflammation. A concerted effort to change lifestyles to prevent the development of coronary heart disease risk factors, and to improve awareness and treatment of risk factors when then develop, is required to halt the epidemic of coronary heart disease that is occurring in Asia.
Introduction
Coronary heart disease (CHD) is the leading cause of death worldwide. While the incidence of CHD is falling in most developed countries, it is increasing in developing countries, such that CHD is now the leading cause of death, surpassing infectious diseases, in the majority of developing countries (except the sub-Saharan region). Using Singapore as an example, we review the reasons for changes in the rates of heart disease, and the implications for the prevention of cardiovascular disease in Asia.
Trends for Coronary Heart Disease in the Developed Countries
The mortality rates from CHD have declined steadily in the developed countries such as the United
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cause of hospitalization in Singapore, which constituted 3.4% of hospital admissions in 2008 and 3.7% in 2010 9) . When compared to Chinese populations from other countries, the CHD mortality in Singapore Chinese males was double of that in Hong Kong or China 11) . This suggests that, although the rates of CHD are lower in Asia, Asians do not enjoy any specific protection from CHD.
In line with this, Asia is rapidly becoming the epicentre for CHD in the world. It is estimated that more than 60% of the global burden of CHD occurs in developing countries, with the majority occurring in Asia 12) . Over the past two decades, a rapid economic transition has taken place, driven largely by a positive change in the demographic structure in the working-age population in Asia. The high productivity in the economy and rising personal income have greatly transformed the socioeconomic landscape in Asia and has been accompanied by a shift from agricultural economies to service-based economies, diets composed of dense calories and high in animal fats, higher rates of smoking and obesity, and rapid urbanization and modern transportation that results in a more sedentary lifestyle. In India, cardiovascular diseases and diabetes mellitus are responsible for about half of total non-communicable deaths. In a metaanalysis of CHD prevalence in India, urban Indian populations experienced a dramatic increase in the CHD prevalence from 1.05% in 1960 to 9.67% in 1995, which paralleled the dramatic increase in the rate of obesity and hypertension 13, 14) . Other studies on the prevalence of CHD in India showed that the prevalence of CHD has almost doubled in the rural areas and increased nine-fold in the urban populations, and that the rates are higher in South India compared to the north 15) . Furthermore, CHD is affecting more young individuals. Between 2000 and 2030, about 35 percent of all CHD deaths in India are predicted to occur among those age 35 to 64, compared with only 12 percent in the United States and 22 percent in China 16) . In China, according to the Sino-MONICA project 17) , the age-standardized incidence of CHD increased by 2.7% per year and 1.2% in women during the period of 1984 to 1997 in Beijing . The prevalence of CHD is six times higher in urban than in rural populations. Total mortality from CHD accounts for 9% of total deaths in urban population and 4% in rural population in China. Hypertension, smoking and overweight are the main contributors to the development of CHD in the Chinese population 17) . Without aggressive healthcare reform and aggressive risk factors management, the CHD events are predicted to increase by more than 50% by States and United Kingdom. In the United States, the death rate from CHD has declined 27.8% over the past decade, partly due to better control of blood pressure and low density lipoprotein cholesterol (LDL-C) levels 1) . In the United Kingdom, death rates from CHD have fallen by 44% in the last decade for people under 75 years of age 2) . Despite these declines, CHD remains the leading cause of death and disability in developed countries. Nearly 1 of every 3 deaths in the United States is attributable to CHD 1) . Furthermore, better healthcare that results in lower CHD mortality and longer life expectancy also leads to a paradoxical increase in the burden of cardiac healthcare cost in these countries.
Some of the declines in CHD rates relate to reductions in the levels of risk factors for CHD. The MONICA (Multinational MONItoring of trends and determinants in CArdiovascular disease) project, performed during the 1980s and 1990s, showed that the relationship between changes in risk factor scores and changes in event rates was substantial, and that changes in risk factors explained almost half the variation in event rates in men but less in women 3) . In the United Kingdom, more than half of the decline in CHD mortality could be attributed to a reduction in major risk factors, especially the smoking rate 4) . A recent study reported a strong socioeconomic influence on the CHD mortality rates in Europe, where faster proportional declines of mortality from CHD was seen in the upper socioeconomic groups (by educational level and occupation class) than in the lower socioeconomic groups 5) .
Trends for CHD and Cardiovascular Risk Factors in Singapore and in Asia
Singapore is one of the more developed countries among Southeast Asia countries, with a gross domestic product (GDP) per capita of $56,532 US dollars in 2010 6) . The urbanization rate was estimated at 59% in 1960s, and has been 100% since 1980 7) . Parallel to the prospering economy and rapid urbanization, a rising incidence of CHD was observed that peaked in the 1980s. This incidence has since declined steadily. The overall age-standardized event rates of myocardial infarction in Singapore decreased from 98.2 to 83.0 per 100 000 residents from 1991 to 1999. This change translated to an average annual reduction of 2.3% 8) . As a cause of mortality CHD has decreased from 19.2% in 2009 to 18.7% in 2010 9) . Nonetheless, the age-adjusted mortality for CHD in Singapore is one of the highest in the world, surpassing that in several developed countries 10) . CHD is the third major half of adult Singaporean met or exceeded their recommended intake of cholesterol (100 mg per 1000 kcal of RDA for energy). More Chinese and Malays met or exceeded the recommended cholesterol intake compared to the Asian Indians.
At the same time that nutrient intake is increasing, there is a large proportion of the population do not exercise. The recent 2010 National Health Survey indicates that 39.1% do not participate in sufficient physical activity 20) . Chinese ethnicity is associated with lower levels of total physical activity than Malay and Asian Indian ethnicity 21) . As a consequence, the prevalence of obesity ( ). The prevalence of obesity is highest among the Malays, followed by the Asian Indians and Chinese. The prevalence rate of current smoking also increased to 14.3% in 2010 from 12.6% in 2004. Most of the current smokers are males, with the proportion of Malay smokers being 1.5 times more than the Chinese and Asian Indians. Only 3.2% of adult Singaporeans reported to be regular drinkers of alcoholic beverages (≥ 4 days a week), with Chinese being the group that is more likely to be regular drinkers 22) . Genome-wide association studies (GWASs) have identified genetic variants that are associated with various metabolic diseases. These discoveries enable further research to refine existing pathways and to test new pathogenic pathways that lead to metabolic diseases towards finding more effective treatments with fewer side effects. However, these genetic variants explain only a small proportion of the variance of metabolic disorders. They do little to explain the ethnic differences observed 23) . As an example, the Genetic Investigation of ANthropometric Traits (GIANT) consortium, recently examined almost 250,000 samples and found a strong signal at the FTO locus that was associated with body weight 24) . They reported a between-homozygotes difference in weight of around 2.5 kg. The effects at other loci were smaller, and in combination, these variants explained no more than 1%-2% of overall variation in adult body mass index. Accumulating evidence suggests that the weight difference observed in the individuals with the FTO variants compared to those without FTO variants, is modulated by the levels of physical activity. Low physical activity seems to accentuate the effect of the FTO variant on body fat accumulation 25) . In another metaanalysis of 45 studies of adults and nine studies of adolescents and children, the association of the FTO risk allele with the odds of obesity was attenuated by 2030 in China.
Drivers of the Increase in CHD Rates in Singapore
Demographic Transition in Singapore Singapore is facing the woes of a rapidly ageing society. This is due to a reduction in fertility rates and increased life expectancy. The number of births per woman fell from a 4.7 in 1965 to 1.4 in 2001. The total fertility rate has dropped to a record low of 1.15 in 2010 18) . At the same time, life expectancy in Singapore is now estimated at 82.1 years, just slightly below that in Japan (82.2 years). The life expectancy for females is higher at 84.3 years compared to males at 79.6 years 9) . The number of adults aged 24-64 per elderly person aged 65 years and over has declined gradually from 13.5 in 1970 to 6.7 in 2012. Together these trends results in a shift in the demographic profile of the Singapore population to assume a 'bee-hive' distribution with a larger proportion of older individuals over the past decade 18) . This demographic transition has been accompanied by an epidemiologic transition, with an increase in the rates of chronic noncommunicable diseases. Cancer and cardiovascular diseases are now the two main causes of death in Singapore 9) .
Nutritional and Lifestyle Transition
There is a close association between dietary patterns and the level of physical activity and the risks of developing chronic diseases such as cancer, cardiovascular diseases and diabetes mellitus. With increasing affluence among the Singapore population, significant changes in the patterns of food intake and dietary practices have taken place. Compared with 1998, protein, fat and carbohydrate intake was significantly higher in 2004 such that more adult Singaporeans in 2004 had excessive intakes of energy, total fat, saturated fat and cholesterol 19) . The greatest increase was observed in males and in Malays. Nearly half of the adult Singaporeans met or exceeded the recommended daily caloric intake appropriate for their gender and age. Two in five adult Singaporeans met or exceeded their recommended intake for carbohydrate and total fat. Fat intake represented close to 30% of the total energy intake with almost 39% of the total fat consisting of saturated fat. Of great concern, the proportion of adult Singaporeans with excess total fat intake increased from 24.9% in 1998 to 42.7% in 2004. While more Chinese exceeded the recommended daily protein intake, Asian Indians tended to consume more fat than other ethnic groups. Alarmingly, more than were treated attain the LDL-cholesterol treatment goal. Although statins are the preferred lipid lowering drug, the median dose of the statins is similar across all cardiovascular risk categories.
C-reactive protein (CRP) is an inflammatory biomarker for cardiovascular disease that might play a role in further stratifying individuals for statins therapy beyond LDL-cholesterol levels. In the Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) study, statin therapy (rosuvastatin 20 mg/day) given to apparently healthy individuals with low LDL-cholesterol levels but elevated CRP levels reduces major cardiovascular events and mortality 29) . We found that a large proportion of apparently healthy adults in Singapore (~30%) would qualify for statin therapy based on elevated CRP levels (defined as ＞2 mg/L) 30) . Importantly, the main determinants of high CRP levels that are modifiable are central obesity and smoking 30) . The findings indicate that lifestyle modification has an important role in reducing the risk of cardiovascular disease in these individuals.
Ethnic Variation and Risk Factors for Coronary Heart Disease in Singapore
Singapore is a multi-ethnic society, consisting of three major ethnic groups in Asia, i.e. Chinese, Malays and Asian Indians which differ in cultural, dietary and lifestyle practices. They also exhibit different rates of cardiovascular disease. Several previous reports have indicated that the incidence of CHD is highest in Asian Indians follows by Malays and Chinese, for both males and females. However, it appears recently that Malays may have surpassed Asian Indians in the incidence of CHD 31) . The case-fatality rate after a myocardial infarction was highest in Malays than in Chinese or Asian Indians for both short-term and longterm follow-up 8) . The stroke prevalence rate was highest among Chinese men, and lowest among Malay women 32) . Some of these ethnic differences may relate to differences in the levels of risk factors and their control in the various ethnic groups. In 2004, the prevalence of diabetes mellitus was highest among the Indians (15.3%), followed by the Malays (11.0%) and Chinese (7.1%). Malays were more likely to have undiagnosed diabetes while amongst those with diagnosed diabetes Asian Indians were the least likely to achieve good glycaemic control. Hypertension was more common in Malays, and Malays were also more likely to be unaware of hypertension and more likely to have suboptimal blood pressure control when aware 27% in physically active adults, further reinforcing the intricate interplay between physical activity and genetic susceptibility to obesity 26) . This highlights that even when genetic variants predisposing to metabolic and cardiovascular disease are present, lifestyle modification can still attenuate this risk. As such, these should not detract from the public health interventions required to reduce the burden of CHD.
Risk Factors for Cardiovascular Disease and Their Control
The Singapore population exhibits high levels of risk factors for CHD. The crude prevalence of diabetes mellitus was 8.2% based on the data from the 2004 Singapore National Health Survey 22) . About 50% of those with diabetes mellitus had not been previously diagnosed, with a larger proportion undiagnosed seen among Malays. Only 1 in 4 of those with known diabetes mellitus achieved good glycaemic control (defined as HbA1C＜7%). A recent health survey in 2010 shows an increase in the prevalence of diabetes mellitus, which now affects about 11.3% of the population.
Hypertension is also common among adults in Singapore. The age-standardized prevalence of hypertension increased from 24.0% in 1992 to 28.0% in 1998. The age-standardized prevalence has since declined and levelled off at about 24.0% in 2004 and 2010 9) . Among those aged 60 and above, one in every two adults is hypertensive. A large proportion of people with hypertension are not aware of the diagnosis. While the majority of those who are aware of the diagnosis are on antihypertensive treatment, few have their blood pressure under control (＜140/90 mmHg) 27) . We have also examined the burden of hypercholesterolemia in Singapore using the NCEP-ATPⅢ guidelines with an intention to provide better information on the treatment gap between what is recommended in the guidelines and what is occurring in the population 28) . About half of adult Singaporeans (48.1%) have elevated LDL-cholesterol levels based on their estimated risk of cardiovascular disease. A significant proportion is unaware of having hypercholesterolemia (~20%), and a substantial number (~40%) of them would qualify for an initiation of lipid-lowering therapy to lower the risk of cardiovascular disease. We also found that the use of lipid-lowering therapy and goal achievement are suboptimal, especially among those who are at high-risk of CHD. Among those who are aware of hypercholesterolemia, a large proportion is not on lipid-lowering therapy (60.7%), and only half of those in the high-risk of CHD who recommendations require three or more cardiovascular risk factors to constitute metabolic syndrome 38) . Based on the data from the 1998 Singapore National Health Survey, the prevalence of metabolic syndrome among adult Singaporeans was 20.2% by the IDF criteria and 26.9% by the AHA/NHLBI criteria 39) . This difference occurs because a fairly large proportion of individuals with 3 or more features of the metabolic syndrome did not have central obesity. Despite the absence of central obesity, these individuals manifest significant metabolic abnormalities and possess a similar risk of future coronary heart disease compared to those with central obesity 40) . While Asian Indians have a greater tendency to exhibit central obesity, Malays have a greater tendency towards metabolic syndrome without central obesity.
This suggested to us that the association between obesity and insulin resistance may differ between ethnic groups. Recently, we examined the hypothesis that ethnicity modulates the association between obesity and other metabolic disorders. We examined the changes in insulin resistance, inflammation (measured by CRP levels) and adiponectin levels with increasing body mass in Chinese, Malays, and Asian Indians 41) . We observed that the relationship between body mass index (BMI) and these metabolic parameters differed between ethnic groups. At lower BMI, Asian Indians were more insulin resistant, had higher levels of CRP and lower levels of adiponectin. However, the impact on all three parameters (insulin resistance, CRP, and adiponectin) with an increase in the BMI was greater in Chinese than in Malays than in Asian Indians such that, at high levels of BMI, no differences were observed. These relationships remain robust when waist circumference was used in place of BMI. This study suggests that some ethnic groups (e.g. Chinese) are more metabolically susceptible to the effects of increasing adiposity (obesity-dependent pathways). In other ethnic groups (e.g. Asian Indians) the pathogenesis of insulin resistance may not be particularly dependent on increasing adiposity (obesity-independent pathways). The role of adipose tissue expansion, adipose tissue function or maladaptive ectopic fat deposition in mediating these ethnic differences is currently undergoing further study.
Concluding Remarks
The experience in Singapore has taught us several things. Firstly, although the rates of cardiovascular disease are low in Asia compared to developed countries, Asians do not enjoy any special protection from cardiovascular disease. The same factors that have driven of their hypertension 27) . In relation to hyperlipidemia, this was more common in Asian Indians and Malays, and they were less likely to achieve LDL-C goal compared with Chinese. Finally, elevated CRP levels were about two times more common in Asian Indians and Malays than in Chinese, even after adjustment for other known factors that might affect the CRP levels.
We have also found that the impact of some of these risk factors on the risk of CHD may differ between ethnic groups. In a 10-year prospective observational study that involved 5,707 participants of Chinese, Malay and Asian Indian participants from 3 cross-sectional studies conducted in Singapore, Yeo KK et al. showed that ethnicity modified the risk of CHD associated with diabetes mellitus 33) . They showed that over and above the increased baseline risk of CHD, diabetes mellitus had a larger effect on the risk of CHD in Asian Indians than in Chinese and Malays 33) . The population attributable risk of CHD related to diabetes mellitus was 40.9% in Asian Indians compared with 27.9% in Malays and 11.0% in Chinese.
Ethnicity Modulates the Effect of Increasing Adiposity on Metabolic Traits
Over the past decade, there have been intense investigations on the impact of ethnicity on metabolic traits, particularly those related to insulin resistance. We have previously shown that Asian Indians are the most insulin resistant followed by Malays and Chinese 34) . This observation is true for both males and females. Our results are in concordance with other reports from multi-ethnic populations (e.g. M-CHAT) that found Asian Indians were more insulin resistant when compared to Caucasians 35) . Liew CF et al. reported that, for the same body mass index, Asian Indian males had higher fasting insulin and leptin levels, greater percent body fat but lower insulin sensitivity (measured by hyperinsulinemic euglycaemic clamp, the gold standard to quantify insulin sensitivity) than Chinese males 36) . The metabolic syndrome is defined by a cluster of cardiovascular risk factors and is closely linked to insulin resistance. These cardiovascular risk factors include central obesity, hypertension, glucose intolerance, high triglycerides and low HDL-cholesterol. The presence of the metabolic syndrome predicts the development of diabetes mellitus and cardiovascular disease. The International Diabetes Federation (IDF) definition for metabolic syndrome requires the presence of central obesity, and two or more of the other four cardiovascular risk factors 37) . The AHA/NHLBI up the rates of cardiovascular disease in developed countries will drive up the rates of cardiovascular disease in Asia. Some of these, such as greater life expectancy and an aging population, we cannot do anything about. However, there are other factors that can and should be addressed. These include nutritional and lifestyle changes such as excess and unhealthy nutrient intake, cigarette smoking, and reduced physical activity. In addition, many people are unaware of cardiovascular risk factors that are present in themselves, and even when they are aware, they are suboptimally treated. Interventions to address these issues are likely to be successful even though cardiovascular disease and its risk factors have a significant genetic contribution to their pathogenesis, due to the presence of gene-environment interactions. Finally, some ethnic groups appear to be particularly susceptible to develop cardiovascular disease. Emerging evidence suggests that different pathways may be involved. Specifically, Chinese may be particularly prone to develop diabetes mellitus and metabolic disease in the face of rising obesity, whereas in Asian Indians, obesity independent pathways may play a different role. This suggests the possibility that we may need to tailor and prioritize interventional programs for specific populations to address those issues that are most urgent in that population.
